- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.12. | Trump to appoint David Sacks as White House AI, crypto czar | ||
| 06.12. | Cash-strapped Cyclacel cuts costs as it searches for financial lifeline | ||
| 06.12. | Chasing Merck, BioNTech and DualityBio post first clinical data on ADC | ||
| 06.12. | PreciseDx's digital pathology AI on par with genomic testing in predicting breast cancer recurrence risks: study | ||
| 06.12. | What can we learn from 2024's biotech IPOs? | ||
| 06.12. | Chutes & Ladders-Stanford economist is Trump's NIH pick | ||
| 06.12. | AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval | ||
| 05.12. | Cleerly collects $106M for its coronary artery scanning AI | ||
| 05.12. | Protara shares spike after cell therapy shows high response rate, no severe side effects in bladder cancer trial | ||
| 05.12. | Insulet nets $452M in damages from insulin pump rival EOFlow in trade secrets suit | ||
| 05.12. | RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response | ||
| 05.12. | Atlas unveils a new $450M fund targeted at biotechs 2 years after its last | ||
| 05.12. | GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's | ||
| 05.12. | Sanofi-backed Nuvig marches lead autoimmune therapy into phase 2 with $161M series B | ||
| 04.12. | CRO and clinical trial markets set for growth by 2030, especially in Asia-Pacific region: reports | ||
| 04.12. | Franklin Biolabs, the genetic medicines CRO founded by James Wilson, names new chief exec | ||
| 04.12. | Genmab buys 2nd anti-glycan antibody from Scancell, commits up to $630M in biobucks | ||
| 04.12. | Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program | ||
| 04.12. | Zimmer Biomet's knee implants collect FDA green lights as cementless alternatives | ||
| 04.12. | Applied Therapeutics' trial conduct scrutinized in FDA warning letter | ||
| 04.12. | GSK goes East again, snagging option on preclinical DualityBio ADC for $30M | ||
| 04.12. | RNA-targeting molecule from Arrakis allows muscles to relax in mice with myotonic dystrophy | ||
| 04.12. | GSK axes hepatitis B vaccine trial after missing efficacy goal | ||
| 04.12. | Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic | ||
| 03.12. | Relay passes baton to Elevar, handing off NDA-ready rare cancer asset for up to $500M |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
